Original ArticleIntracranial Angiomatoid Fibrous Histiocytoma: Case Report and Literature Review
Introduction
Angiomatoid fibrous histiocytoma (AFH) is a rare, low-grade soft tissue tumor that arises primarily from deep dermal and subcutaneous tissue of the extremities in children and young adults.1, 2, 3 It accounts for nearly 0.3% of all soft tissue tumors. Most patients present in the first 3 decades of life, but there is a wide distribution of age.4 AFH has an indolent behavior with 2%–11% local recurrence and <1% metastasis. No factors have been identified to alter prognosis with the exception of wide local excision of tumor.5
Before Enzinger's first official report of AFH in 1979, this entity was misdiagnosed as sclerosing hemangioma, dermatofibroma, and fibrous histiocytoma, among other diagnoses.3 It was later defined as a variant of malignant fibrous histiocytoma arising in younger populations and at superficial sites as opposed to the typical presentation of malignant fibrous histiocytoma, a tumor within deep soft tissues of older adults.2 AFH lesions tend to be small, ranging from 2–4 cm and reaching a maximum reported size of 10 cm.3 Larger studies of AFH have shown a favorable prognosis with gross total resection (GTR), leading to its identification as a separate entity from malignant fibrous histiocytoma. As more specific markers are becoming available, this rare tumor is being identified in more locations than previously noted.4
AFH rarely presents intracranially. Four reports of intracranial AFH exist in the literature to date, 3 primary lesions and 1 that was thought to be a metastasis on the basis of imaging alone.6, 7, 8 These primary lesions were initially misdiagnosed as cavernous malformations or unusual meningioma, but the correct diagnosis was made after using a combination of histologic, immunohistochemical, and molecular features characteristic of AFH.
In this report, we present a rare case of primary, intracranial petrous apex AFH in an older female patient.
Section snippets
Case Report
A 58-year-old female presented with right facial weakness, pain, and numbness. Notably, she had also experienced a 30-pound unintentional weight loss over the previous year and a previous tooth infection several months prior. The facial pain had developed shortly after her tooth infection but persisted for several months and became unbearable. The patient attributed her weight loss to the loss of taste sensation on the right side of her tongue and intolerable pain while eating. On physical
Discussion
AFH is a benign, soft tissue tumor arising in dermal and subcutaneous tissue that tends to affect patients in the first few decades of life. This rare tumor shares histologic and radiographic features with other fibrous lesions, thus lending to its diagnostic difficulty. As mentioned previously, the first diagnosis of AFH was made in 1979 by Enzinger.3 This first case was initially misdiagnosed as multiple other pathologies. Since then, there have been numerous case reports classifying AFH as a
Conclusion
In this report, we present a rare case of primary intracranial AFH in a 58-year-old patient. Before this, only 3 cases of primary intracranial AFH had been reported in individuals ranging from 17–35 years old. The radiographic and histopathologic findings were nonspecific and initially pointed toward a schwannoma, clinically, and meningioma, pathologically. Further pathologic consultation finally supported the diagnosis of AFH. We suspect there are more cases of intracranial AFH that are
References (10)
- et al.
Aneurysmal sclerosing hemanigoma of skin
Arch Dermatol
(1966) - et al.
Angiomatoid malignant fibrous histiocytoma. A follow-up study of 108 cases with evaluation of possible histologic predictors of outcome
Am J Surg Pathol
(1990) Angiomatoid malignant fibrous histiocytoma: a distinct fibrohistiocytic tumor of children and young adults simulating a vascular neoplasm
Cancer
(1979)- et al.
Angiomatoid malignant fibrous histiocytoma: cytologic, immunohistochemical, ultrastructural, and flow cytometric study of 20 cases
Mod Pathol
(1990) - et al.
Angiomatoid fibrous histiocytoma. WHO classification of tumours pathology and genetics of tumours of soft tissue and bone
(2002)
Cited by (34)
A case of intracranial angiomatoid fibrous histiocytoma
2023, Asian Journal of SurgeryPrimary Intracranial Angiomatoid Fibrous Histiocytoma: Two Case Reports and Literature Review
2020, World NeurosurgeryCitation Excerpt :Angiomatoid fibrous histiocytoma (AFH) is a rare, fibrohistiocytic, soft-tissue neoplasm that represents 0.3% of all soft-tissue tumors.1,2
Adult Intracranial Myxoid Mesenchymal Tumor with EWSR1-ATF1 Gene Fusion
2020, World NeurosurgeryCitation Excerpt :Prior reports of IMMT have noted similarities of this tumor to the myxoid variant of AFH. There have been only a handful of reports identifying AFH intracranially, and among these only 1 case demonstrated a myxoid morphology in addition to classical AFH features, while harboring an EWSR1 gene fusion (Table 1).6-10 The distinguishing features of AFH include clear lymphocyte cuffing with a fibrous pseudocapsule and blood-filled spaces.
Intracranial Angiomatoid Fibrous Histiocytoma with EWSR1-CREB Family Fusions: A Report of 2 Pediatric Cases
2019, World NeurosurgeryCitation Excerpt :AFHs usually involve the limb extremities of adolescents and young adults; the median age at presentation is 14 years.2 The brain has represented a very rare primary site, with only 5 “typical” AFH adult patients reported to date (Table 1).4,9,11-13 In the past 2 years, intracranial AFH-like tumors have been reported in both children and adults, characterized by increased vascularity, epithelioid cells, and a prominent myxoid background.6-8,10
Angiomatoid fibrous histiocytoma of the radial pulse groove
2018, Annales de Dermatologie et de VenereologiePotential prognostic determinants for FET::CREB fusion-positive intracranial mesenchymal tumor
2024, Acta Neuropathologica Communications
Conflict of interest statement: The authors have no conflicts of interest with regard to this submission.